DNA Damage and Repair in Human Cancer: Molecular Mechanisms and Contribution to Therapy-Related Leukemias
Open Access
- 27 July 2012
- journal article
- review article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 9 (8) , 2636-2657
Abstract
Most antitumour therapies damage tumour cell DNA either directly or indirectly. Without repair, damage can result in genetic instability and eventually cancer. The strong association between the lack of DNA damage repair, mutations and cancer is dramatically demonstrated by a number of cancer-prone human syndromes, such as xeroderma pigmentosum, ataxia-telangiectasia and Fanconi anemia. Notably, DNA damage responses, and particularly DNA repair, influence the outcome of therapy. Because DNA repair normally excises lethal DNA lesions, it is intuitive that efficient repair will contribute to intrinsic drug resistance. Unexpectedly, a paradoxical relationship between DNA mismatch repair and drug sensitivity has been revealed by model studies in cell lines. This suggests that connections between DNA repair mechanism efficiency and tumour therapy might be more complex. Here, we review the evidence for the contribution of carcinogenic properties of several drugs as well as of alterations in specific mechanisms involved in drug-induced DNA damage response and repair in the pathogenesis of therapy-related cancers.Keywords
This publication has 105 references indexed in Scilit:
- Altered Hematopoietic Cell Gene Expression Precedes Development of Therapy-Related Myelodysplasia/Acute Myeloid Leukemia and Identifies Patients at RiskCancer Cell, 2011
- DNA interstrand crosslink repair and cancerNature Reviews Cancer, 2011
- NMR-Based Metabolomic Analysis of the Molecular Pathogenesis of Therapy-Related Myelodysplasia/Acute Myeloid LeukemiaJournal of Proteome Research, 2011
- Synthesis and characterization of an O6-2′-deoxyguanosine-alkyl-O6-2′-deoxyguanosine interstrand cross-link in a 5′-GNC motif and repair by human O6-alkylguanine-DNA alkyltransferaseOrganic & Biomolecular Chemistry, 2010
- Therapy-Related Myeloid LeukemiaSeminars in Oncology, 2008
- Survival and tumorigenesis in O6-methylguanine DNA methyltransferase-deficient mice following cyclophosphamide exposureMutagenesis, 2008
- Cross-Linking of the DNA Repair Protein O6-Alkylguanine DNA Alkyltransferase to DNA in the Presence of Antitumor Nitrogen MustardsChemical Research in Toxicology, 2008
- DNA topoisomerase II, genotoxicity, and cancerMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2007
- Fludarabine-mediated suppression of the excision repair enzyme ERCC1 contributes to the cytotoxic synergy with the DNA minor groove crosslinking agent SJG-136 (NSC 694501) in chronic lymphocytic leukaemia cellsBritish Journal of Cancer, 2007
- Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemiaBritish Journal of Cancer, 2006